Delivery Order SPE2DR25D2014-SPE2DR26FZ66K
- Not listed
- The Defense Logistics Agency awarded a $1,505.59 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The place of performance is listed as Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,403.24 for Lantus SoloStar 100 Unit/mL 3mL insulin on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $7,716.36 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL quantities. This competitive award, issued on November 4, 2025, represents a Firm Fixed Price delivery order with an ultimate completion date of November 5, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a non-set-aside award, this contract was competed among eligible...
- The Defense Logistics Agency awarded a delivery order contract valued at $2,110.44 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL insulin pens (3mL). This competitively awarded, firm fixed-price delivery order was issued on August 8, 2025, with an ultimate completion date of August 11, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a $9,503.98 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar insulin (100 units/mL in 3mL formulation) on October 27, 2025, with completion targeted for October 28, 2025. This is a firm fixed-price, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania facility. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $1,317.48 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Lantus SoloStar 100 Unit/ML 3ML insulin pens. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of July 24, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award falls under the company's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,022.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens, with an ultimate completion date of September 29, 2025. This is a non-set-aside competitive award issued to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a procurement action under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, which is valued...
- The Defense Logistics Agency awarded a $1,534.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin pens. The award, made on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a non-set-aside competitive procurement. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $4,068.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL pen format. This is a non-set-aside competitive award with an ultimate completion date of September 29, 2025, and performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,443.36 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML 3ML insulin pens, with an ultimate completion date of November 5, 2025. This competitive, firm fixed-price delivery order was issued on November 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the contractor's ability to compete in open...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ66KDelivery Order
The Defense Logistics Agency awarded a $1,237.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL pen format, with completion scheduled for November 10, 2025. This is a non-set-aside competitive award issued to the Conshohocken, Pennsylvania-based pharmaceutical distributor, which serves as a critical vendor for federal medical procurement. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and running through December 2026. AmerisourceBergen Drug Corp leverages its comprehensive IDC vehicle to supply a broad range of pharmaceutical products and medical commodities to support military healthcare systems worldwide, including serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare organizations. The parent IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. This delivery order for insulin represents routine execution of the company's role as a primary pharmaceutical vendor within the DLA's supply chain, supporting military personnel and beneficiary healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 11/7/25 |